Tom Martin (@tombmt133) 's Twitter Profile
Tom Martin

@tombmt133

Associate Chief Hematology, Director- Blood and Marrow Transplant,

ID: 812851718014701568

calendar_today25-12-2016 02:45:26

212 Tweet

2,2K Followers

153 Following

Tom Martin (@tombmt133) 's Twitter Profile Photo

Great collaboration between IMF and MSkCC, a great example for all of us to develop and encourage locally - need to reach all patients!

Tom Martin (@tombmt133) 's Twitter Profile Photo

Then @SOHO2024 at 8:00AM - join us for Supportive Care including an amazing CART case=> Dr Martin, MRD update with Dr Nooka and Maintenance with Dr CALLANDER - should be great

Tom Martin (@tombmt133) 's Twitter Profile Photo

Soho24 - and Wednesday 6:15PM will have our first MM Poster Walk - 4 posters - Perseus update (NDMM-TE), Iber-VD -new data (NDMM- TI), DREAMM-7 update RRMM, Mezi- triplet RRMM plus many excellent posters to view!!!! C ya there Society of Hematologic Oncology (SOHO)

Tom Martin (@tombmt133) 's Twitter Profile Photo

Hira Mian giving a great talk on frailty: need to stages the MM, and “stage the age” - the simplified faulty index (age, ECOG,CCI) can be done on everybody!!

Tom Martin (@tombmt133) 's Twitter Profile Photo

Canada-Myeloma - amazing talk by Vincent Rajkumar on progress in MM treatments and use of T-cell therapies!! Great meeting - thanks Hira and Paola

Canada-Myeloma - amazing talk by Vincent Rajkumar on progress in MM treatments and use of T-cell therapies!! Great meeting - thanks Hira and Paola
Tom Martin (@tombmt133) 's Twitter Profile Photo

Hold the phone: many may benefit from CAR in first relapse- fxn HR, HR cyto,etc and remember the PFS/OS curves are ITT (15%) did not receive CAR. Len-refractory -a tough group to treat- 🚗!

VJHemOnc (@vjhemonc) 's Twitter Profile Photo

🔊 New podcast alert! Dive into the latest in immunotherapy for high-risk #MultipleMyeloma with expert insights from Ajai Chari, Krina Patel, Tom Martin, Niels Van de Donk, & Saad Z. Usmani MD MBA FACP 🇺🇸🇵🇰 at #iwHRMM2024. 🎙️ Tune in now: ow.ly/b11h50U5SaE #HemOnc #ImmunoOnc

🔊 New podcast alert! Dive into the latest in immunotherapy for high-risk #MultipleMyeloma with expert insights from <a href="/AjaiChari/">Ajai Chari</a>, <a href="/DrKrinaPatel/">Krina Patel</a>, <a href="/TomBmt133/">Tom Martin</a>, Niels Van de Donk, &amp; <a href="/szusmani/">Saad Z. Usmani MD MBA FACP 🇺🇸🇵🇰</a> at #iwHRMM2024.

🎙️ Tune in now: ow.ly/b11h50U5SaE

#HemOnc #ImmunoOnc
Binaytara (@binaytara) 's Twitter Profile Photo

Join us at #HemeLA25 on Mar 28-29! Register today: buff.ly/412agMQ Co-chaired by Danilov Lab and Dr. Vinod Pullarkat (both from City of Hope), and Tom Martin (UCSF Helen Diller Family Comprehensive Cancer Ctr), this CME/MOC-accredited conference will deliver a comprehensive review of current and emerging

Join us at #HemeLA25 on Mar 28-29! Register today: buff.ly/412agMQ Co-chaired by <a href="/DanilovLab/">Danilov Lab</a> and Dr. Vinod Pullarkat (both from <a href="/cityofhope/">City of Hope</a>), and <a href="/TomBmt133/">Tom Martin</a> (<a href="/UCSFCancer/">UCSF Helen Diller Family Comprehensive Cancer Ctr</a>), this CME/MOC-accredited conference will deliver a comprehensive review of current and emerging
VJHemOnc (@vjhemonc) 's Twitter Profile Photo

Teclistamab: A bright future ahead! Tom Martin (Tom Martin) from UCSF Helen Diller Family Comprehensive Cancer Ctr reflects on the progress of teclistamab at #iwCART25 and the exciting potential for the future. 🌟🧬 #Teclistamab #MMsm #Myeloma #Immunotherapy

Teclistamab: A bright future ahead! 

Tom Martin (<a href="/TomBmt133/">Tom Martin</a>) from <a href="/UCSFCancer/">UCSF Helen Diller Family Comprehensive Cancer Ctr</a> reflects on the progress of teclistamab at #iwCART25 and the exciting potential for the future. 🌟🧬 

#Teclistamab #MMsm #Myeloma #Immunotherapy
Tom Martin (@tombmt133) 's Twitter Profile Photo

Dr Kaur - wonderful job presenting 117 RRMM pats treated with Anito-cel => ORR 97%, no late neurotoxicity to date - interesting for sure